Drug Discovery Solutions for Targeting Lysosomes
Various lysosomal pathways and their components represent potential pharmacological targets for a variety of diseases. CD BioSciences develops potential lysosomal therapeutic targets to provide effective drug discovery solutions, including lysosomal cathepsins, lysosomal membrane permeability and integrity, lysosomal calcium signaling, lysosomal mTOR signaling and lysosomes body degradation pathway. We aim to expand our library of lysosome-specifically targeted drugs diseases.
READ MORE